Clinical Trial Update: GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 study GI-270384 in mild-to-moderate ulcerative colitis sponsored by GlaxoSmithKline has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GI-270384

Snippet

Sponsor: GlaxoSmithKline | Conditions: Ulcerative Colitis | Phase 1 | Status: TERMINATED